Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Katrin Goepfert
Rational Combination of Parvovirus H1 With CTLA-4 and PD-1 Checkpoint Inhibitors Dampens the Tumor Induced Immune Silencing
Frontiers in Oncology
Cancer Research
Oncology
Related publications
The Safety and Tolerability of Combined Immune Checkpoint Inhibitors (Anti-Pd-1/Pd-L1 Plus Anti-Ctla-4): A Systematic Review and Meta-Analysis
BMC Cancer
Cancer Research
Oncology
Genetics
The Efficacy and Safety of Combination of PD-1 and CTLA-4 Inhibitors: A Meta-Analysis
Experimental Hematology and Oncology
Cancer Research
Oncology
Hematology
Survival Outcomes Following Combination Radiotherapy and Immune Checkpoint Inhibitors
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
4) Immune-Related Adverse Events in Endocrine Organs Induced by Immune Checkpoint Inhibitors
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Medicine
Copanlisib in Combination With Anti-Pd-1 Induces Regression in Animal Tumor Models Insensitive or Resistant to the Monotherapies of Pi3k and Checkpoint Inhibitors
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Breast Care
Surgery
Oncology
PD-1 Checkpoint Blockade in Combination With an mTOR Inhibitor Restrains Hepatocellular Carcinoma Growth Induced by Hepatoma Cell-Intrinsic PD-1
Hepatology
Medicine
Hepatology
Infectious Complications Associated With the Use of Immune Checkpoint Inhibitors in Oncology: Reactivation of Tuberculosis After Anti PD-1 Treatment
Clinical Microbiology and Infection
Medicine
Infectious Diseases
Microbiology
Immune Checkpoint Inhibitors and irAEs
Trends in Immunotherapy
